Intellectual Property India Publishes Patent Application for Antibody-Auristatin Drug Conjugates And Methods Of Making And Using Thereof

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202647096493 A) filed by Systimmune, Inc. on August 10, 2026, for Antibody-Auristatin Drug Conjugates And Methods Of Making And Using Thereof.

Inventors include Zhu, Yi; Wan, Weili; Zhuo, Shi; Lai, Weirong Number; and Zhang, Yong.

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: The application provides antibody-drug conjugates (ADCs) comprising an antibody moiety having a binding affinity to HER2 and a drug moiety derived from auristatin, and methods of making and using such ADCs for treating cancer. The disclosure further provides linker-drug compounds comprising auristatin derivatives, and methods of making and using thereof.

Disclaimer: Curated by HT Syndication.